These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
996 related articles for article (PubMed ID: 26325259)
1. Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy. Gronda E; Genovese S; Padeletti L; Cacciatore F; Vitale DF; Bragato R; Innocenti L; Schiano C; Sommese L; De Pascale MR; Genovese L; Abete P; Donatelli F; Napoli C Cardiol J; 2015; 22(4):459-66. PubMed ID: 26325259 [TBL] [Abstract][Full Text] [Related]
2. Long-Term Outcomes With Cardiac Resynchronization Therapy in Patients With Mild Heart Failure With Moderate Renal Dysfunction. Daimee UA; Moss AJ; Biton Y; Solomon SD; Klein HU; McNitt S; Polonsky B; Zareba W; Goldenberg I; Kutyifa V Circ Heart Fail; 2015 Jul; 8(4):725-32. PubMed ID: 26038537 [TBL] [Abstract][Full Text] [Related]
3. Reduced long-term overall mortality in heart failure patients with prolonged QRS treated with CRT combined with ICD vs. heart failure patients with narrow QRS treated with ICD only. Palmisano P; Accogli M; Pisanò EC; Zaccaria M; De Blasi S; Ponzetta MA; Valsecchi S; Milanese G; Lauretti M; Magliari F Europace; 2016 Sep; 18(9):1374-82. PubMed ID: 26612878 [TBL] [Abstract][Full Text] [Related]
4. Atrial fibrillation in cardiac resynchronization therapy with a defibrillator: a risk factor for mortality, appropriate and inappropriate shocks. van Boven N; Theuns D; Bogaard K; Ruiter J; Kimman G; Berman L; VAN DER Ploeg T; Kardys I; Umans V J Cardiovasc Electrophysiol; 2013 Oct; 24(10):1116-22. PubMed ID: 23889733 [TBL] [Abstract][Full Text] [Related]
5. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy. Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089 [TBL] [Abstract][Full Text] [Related]
6. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block. Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V; J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205 [TBL] [Abstract][Full Text] [Related]
7. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT. Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ; Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234 [TBL] [Abstract][Full Text] [Related]
11. Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry. Zusterzeel R; Spatz ES; Curtis JP; Sanders WE; Selzman KA; Piña IL; Bao H; Ponirakis A; Varosy PD; Masoudi FA; Caños DA; Strauss DG Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S4-11. PubMed ID: 25714821 [TBL] [Abstract][Full Text] [Related]
12. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial. Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831 [TBL] [Abstract][Full Text] [Related]
13. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator. Martens P; Verbrugge FH; Nijst P; Dupont M; Nuyens D; Herendael HV; Rivero-Ayerza M; Tang WH; Mullens W Heart; 2017 Dec; 103(24):1977-1984. PubMed ID: 28716973 [TBL] [Abstract][Full Text] [Related]
14. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study. Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E; J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490 [TBL] [Abstract][Full Text] [Related]
15. Amiodarone is associated with adverse outcomes in patients with sustained ventricular arrhythmias upgraded to cardiac resynchronization therapy-defibrillators. Adelstein EC; Althouse AD; Davis L; Schwartzman D; Bazaz R; Jain S; Wang N; Saba S J Cardiovasc Electrophysiol; 2019 Mar; 30(3):348-356. PubMed ID: 30575185 [TBL] [Abstract][Full Text] [Related]
16. Complete left bundle branch block and smaller left atrium are predictors of response to cardiac resynchronization therapy in advanced heart failure. Imamura T; Kinugawa K; Nitta D; Komuro I Circ J; 2015; 79(11):2414-21. PubMed ID: 26376671 [TBL] [Abstract][Full Text] [Related]
17. Comparative Effectiveness of Cardiac Resynchronization Therapy Among Patients With Heart Failure and Atrial Fibrillation: Findings From the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry. Khazanie P; Greiner MA; Al-Khatib SM; Piccini JP; Turakhia MP; Varosy PD; Masoudi FA; Curtis LH; Hernandez AF; Circ Heart Fail; 2016 Jun; 9(6):. PubMed ID: 27296396 [TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes in cardiac resynchronization therapy-defibrillator recipients 80 years of age and older. Adelstein EC; Liu J; Jain S; Schwartzman D; Althouse AD; Wang NC; Gorcsan J; Saba S Europace; 2016 Mar; 18(3):420-7. PubMed ID: 26487669 [TBL] [Abstract][Full Text] [Related]
19. Cardiac resynchronization therapy is associated with a reduction in ICD therapies as it improves ventricular function. Galve E; Oristrell G; Acosta G; Ribera-Solé A; Moya-Mitjans À; Ferreira-González I; Pérez-Rodon J; García-Dorado D Clin Cardiol; 2018 Jun; 41(6):803-808. PubMed ID: 29604094 [TBL] [Abstract][Full Text] [Related]
20. Functional response to cardiac resynchronization therapy is associated with improved clinical outcome and absence of appropriate shocks. Van Boven N; Bogaard K; Ruiter J; Kimman G; Theuns D; Kardys I; Umans V J Cardiovasc Electrophysiol; 2013 Mar; 24(3):316-22. PubMed ID: 23210664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]